The Hippy
Well-Known Member
Gotta link to that Gb ?class action filed against producer of pot tainted with pesticide
and theyre NO LONGER ORGANIC!!!
OrganiGram - Another Recall!! 1/09/17
- Thread starter Fornfrussen
- Start date
CalyxCrusher
Well-Known Member
What the fuck. Good eye. I wonder if this is while ther organic certifcation has been temporarily pulled. Should have been shut down immediately for poisoning the already sick and dying. On a side note LOLOL nice pricing...............
doingdishes
Well-Known Member
i think it's completley disgusting that they touted the LP's as so clean and safe while any other source was contaminated....now they have egg on their faces and I hope this turns into a positive for patients.
i still have no love for LP's but if they can get a quality product, that would be great...now go for reasonable prices!
i still have no love for LP's but if they can get a quality product, that would be great...now go for reasonable prices!
CannaReview
Well-Known Member
That's because they lost their "organic" certification so they can't claim the products to be organic anymore.
TWO.,...THATS TWO TWO OF THE ONEs THAT WERE CAUGHT..THEY SHOULD GO AFTER THE OTHERS AS WELL!! federally regulated medical-marijuana companies caught up in a tainted-cannabis scare are facing proposed class-action lawsuits from patients who unknowingly ingested banned pesticides.
Mettrum Ltd. and OrganiGram Inc. were both found selling medical marijuana that contained unauthorized chemicals, including the controversial pesticide myclobutanil, which produces hydrogen cyanide when combusted and can lead to serious health problems.
The suit against OrganiGram was filed in Nova Scotia Supreme Court on Monday by Halifax-based Wagners Law Firm, while a separate action against Mettrum was filed in Ontario Supreme Court by the firm Roy O’Connor LLP.
Globe investigation: What's in your weed
Globe investigation: What's not in your weed
Both actions are seeking certification from the courts and are asking that the companies be forced to refund patients’ money, in addition to paying out further damages.
The OrganiGram suit is led by Halifax patient Dawn Rae Downton, who was not previously a marijuana user but was prescribed medical cannabis to alleviate serious back pain, the documents allege.
After taking the product daily, “Ms. Downton began to suffer from severe nausea and vomiting within approximately two weeks after first consuming the Affected Product,” the documents allege. “The severity of the symptoms restricted her ability to stand, walk or leave the house. She was confined to her home and bed for the majority of the time. Even light household chores became unmanageable.”
The Mettrum suit is led by Erin Christiansen, a Thunder Bay woman who unknowingly ingested tainted product purchased from the Toronto-based company, which has since been purchased by Canopy Growth Corp., Canada’s largest medical-marijuana producer.
“I was disturbed to learn that unapproved pest-control products were used on Mettrum’s medical-marijuana plants,” Ms. Christiansen said in a statement. “If I had known there was a risk that Mettrum’s plants had been treated with an unapproved pesticide, I would never have purchased the products.”
Neither OrganiGram CEO Denis Arsenault, nor Mettrum’s owner, Canopy, were immediately available for comment Monday. The allegations have not been proven in court.
The tainted-cannabis problems have led to management shakeups at both companies. Last week, OrganiGram announced a new CEO, Greg Engel, would be taking the reins on March 13, while Mr. Arsenault is moving to the board of directors as executive chairman. And former Mettrum CEO Michael Haines was not retained by Canopy when it closed the deal to purchase the company Jan. 31.
The problems emerged several months ago when Mettrum issued a series of recalls in late 2016 due to the discovery of an unauthorized pesticide, pyrethrin. That led to subsequent tests that turned up banned myclobutanil.
While Mettrum informed some patients of the situation, neither the company nor Health Canada disclosed the discovery of myclobutanil to the broader public, including prospective patients, in their press releases announcing the recalls.
When The Globe and Mail called Mettrum’s customer help line in December, a reporter had to specifically ask about the presence of myclobutanil before the company offered up the information.
Soon after the Mettrum problem came to light, OrganiGram announced its own recall due to myclobutanil, along with a second banned pesticide, bifenazate. Alberta-based Aurora Cannabis Inc. discovered the issue with OrganiGram’s supply when it purchased a bulk shipment from the company and had it tested for contaminants.
Mettrum Ltd. and OrganiGram Inc. were both found selling medical marijuana that contained unauthorized chemicals, including the controversial pesticide myclobutanil, which produces hydrogen cyanide when combusted and can lead to serious health problems.
The suit against OrganiGram was filed in Nova Scotia Supreme Court on Monday by Halifax-based Wagners Law Firm, while a separate action against Mettrum was filed in Ontario Supreme Court by the firm Roy O’Connor LLP.
Globe investigation: What's in your weed
Globe investigation: What's not in your weed
Both actions are seeking certification from the courts and are asking that the companies be forced to refund patients’ money, in addition to paying out further damages.
The OrganiGram suit is led by Halifax patient Dawn Rae Downton, who was not previously a marijuana user but was prescribed medical cannabis to alleviate serious back pain, the documents allege.
After taking the product daily, “Ms. Downton began to suffer from severe nausea and vomiting within approximately two weeks after first consuming the Affected Product,” the documents allege. “The severity of the symptoms restricted her ability to stand, walk or leave the house. She was confined to her home and bed for the majority of the time. Even light household chores became unmanageable.”
The Mettrum suit is led by Erin Christiansen, a Thunder Bay woman who unknowingly ingested tainted product purchased from the Toronto-based company, which has since been purchased by Canopy Growth Corp., Canada’s largest medical-marijuana producer.
“I was disturbed to learn that unapproved pest-control products were used on Mettrum’s medical-marijuana plants,” Ms. Christiansen said in a statement. “If I had known there was a risk that Mettrum’s plants had been treated with an unapproved pesticide, I would never have purchased the products.”
Neither OrganiGram CEO Denis Arsenault, nor Mettrum’s owner, Canopy, were immediately available for comment Monday. The allegations have not been proven in court.
The tainted-cannabis problems have led to management shakeups at both companies. Last week, OrganiGram announced a new CEO, Greg Engel, would be taking the reins on March 13, while Mr. Arsenault is moving to the board of directors as executive chairman. And former Mettrum CEO Michael Haines was not retained by Canopy when it closed the deal to purchase the company Jan. 31.
The problems emerged several months ago when Mettrum issued a series of recalls in late 2016 due to the discovery of an unauthorized pesticide, pyrethrin. That led to subsequent tests that turned up banned myclobutanil.
While Mettrum informed some patients of the situation, neither the company nor Health Canada disclosed the discovery of myclobutanil to the broader public, including prospective patients, in their press releases announcing the recalls.
When The Globe and Mail called Mettrum’s customer help line in December, a reporter had to specifically ask about the presence of myclobutanil before the company offered up the information.
Soon after the Mettrum problem came to light, OrganiGram announced its own recall due to myclobutanil, along with a second banned pesticide, bifenazate. Alberta-based Aurora Cannabis Inc. discovered the issue with OrganiGram’s supply when it purchased a bulk shipment from the company and had it tested for contaminants.
westcoast420
Well-Known Member
Would love to see a lawsuit against health Canada too for dropping the ball so badly on monitoring these operations then not disclosing information to the public until after organisham did.
CannaReview
Well-Known Member
No but its been proven a HC licensed producer broke ACMPR l
If things go right I should have some info soon https://www.rollitup.org/t/its-coming-along.934063/#post-13347693
doingdishes
Well-Known Member
i am looking forward to learning about that